You searched for "interventions"

2097 results found

Should we move towards procedure-specific consent forms?

The consent process represents the patient’s acceptance of the information provided to them and an agreement to undergo an intervention as suggested by a health professional. Effective doctor-patient communication, ensuring the succinct delivery of the necessary points in a way...

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

Eye surgeon gives sight to Cambodians

Professor Sunil Shah has racked up his air miles in recent years. Since 2016, the Consultant Ophthalmologist at Midland Eye and the Birmingham & Midland Eye Centre, has become a repeat visitor to Cambodia where he has led a series...

Vision Surgery SARCS 2026

Vision Surgery XXIV STATE OF THE ART REFRACTIVE & CATARACT SURGERY

Moorfields Education: Joint vitreo retinal and ocular oncology symposium for nurses and allied health professionals

This unique event will provide attendees with up-to-date knowledge of vitreo retinal and ocular oncology conditions and treatments as well as new innovations across both specialities.

The history of ophthalmology: John Argyll Robertson and Douglas Moray Cooper Lamb Argyll Robertson

The author shares the story of an extraordinary father and son, two of the major figures in defining the specialty of ophthalmology as we know it today. The renowned Glasgow Surgeon Peter Lowe described ophthalmic surgery in his legendary surgical...

Michael Burdon to begin term of office as a BCPB Trustee

Michael Burdon begins his term of office as a BCPB Trustee in July 2020, and in October 2020 will become Chairman of the Council when Paul Hunter retires after six years.

Haag-Streit UK announces appointment of Thomas Lenzen as new CEO

Haag-Streit UK is pleased to announce the appointment of Thomas Lenzen as the new Chief Executive Officer (CEO) of the Haag-Streit Group. Thomas Lenzen. With more than two decades of international leadership experience in the med tech industry, Thomas Lenzen...

New GIRFT glaucoma guidance – opportunities for improvement through primary eyecare services

Primary eyecare organisations have welcomed the publication of NHS England's Getting It Right First Time (GIRFT) Best Practice Guidance for Glaucoma Services. If implemented by ICBs as intended, the new guidance should mark an important step forward in the delivery...

Development of retinoblastoma care in Indonesia and the role of multidisciplinary team meetings

In the second article of a two-part series (See Part 1 here), the authors focus on the diagnosis and management of retinoblastoma in Indonesia. COVID-19 doesn’t get thanked for many things, but on 19 December 2020 as the world grew...

IAC vs. IVC chemotherapy for RB

This a single centre retrospective review of consecutive patients between 1997 and 2014, of all sporadic unilateral retinoblastoma (RB) group D cases, treated with combined intravenous chemotherapy (IVC) and focal treatments (1997- 2008), or intra-arterial chemotherapy (IAC) treatment (2008 to...

VKH outcomes with pulse IV steroids

This is a retrospective review of clinical case notes records of 111 Vogt-Koyanagi-Harada (VKH) patients between 1999 and 2015 from a single centre in Tokyo, Japan. The mean age at presentation was 41 years and the median follow-up period was...